Physician profile
Larry Moss
NPI 1518962208
$614.65
in general payments reported to CMS, 2019-2025
9 companies · $99.72 in 2025
The $99.72 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.42 · 2020: $3.82 · 2021: $36.90 · 2022: $189 · 2023: $3.08 · 2024: $198 · 2025: $99.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298 · Education: $3.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.92 |
| Education | $3.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $402.93 | 2019-2024 | Lokelma |
| Amgen INC. | $51.14 | 2019-2021 | |
| Novo Nordisk INC | $30.95 | 2025 | Ozempic |
| Genzyme Corporation | $28.45 | 2025 | |
| Ani Pharmaceuticals, INC. | $25.45 | 2025 | Purified Cortrophin Gel |
| Vifor Pharma, INC. | $23.88 | 2019-2022 | |
| Daiichi Sankyo INC. | $22.44 | 2024 | Injectafer |
| Glaxosmithkline, LLC. | $14.87 | 2025 | Benlysta |
| Travere Therapeutics, INC. | $14.54 | 2020-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.